Join to view full profile
3901 RAINBOW BLVDMs 3002Kansas City, KS 66160
Phone+1 913-588-6074
Fax+1 913-588-3867
Dr. Yu is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alan Yu is a nephrologist based in Kansas City, KS, with expertise in hypertension, general nephrology, acute renal failure, chronic kidney disease, and glomerular disease. He completed his residency in Internal Medicine and a fellowship in Nephrology at Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital. Dr. Yu has contributed to several publications in reputable journals and has been involved in clinical trials, such as a study on Niacinamide in Polycystic Kidney Disease. His accolades include being named a Regional Top Doctor by Castle Connolly and becoming a Fellow of the American College of Physicians. Additionally, he holds CMS Meaningful Use Stage 1 Certifications from Epic Systems Corporation.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1995 - 1996- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1992 - 1995
School of Clinical Medicine, University of CambridgeClass of 1989
Certifications & Licensure
CA State Medical License 2002 - Present
KS State Medical License 2011 - 2027
MO State Medical License 2021 - 2027
MA State Medical License 1995 - 2003
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Apelin Inhibits Cyst Growth and Improves Kidney Function in Mice with Polycystic Kidney Disease.Duuamene Nyimanu, Anubhav Chakraborty, Stephen C Parnell, Darren P Wallace, Alan S L Yu
Kidney360. 2026-10-02 - Renal blood flow and progression to kidney failure in ADPKD.Kristen L Nowak, Timothy P Copeland, Elaine Ku, Mark J Sarnak, Zhiying You
Nephrology, Dialysis, Transplantation. 2026-09-30 - CRISPR activation of endogenousincreases polycystin-1 levels and suppresses cellular features of ADPKD.Anubhav Chakraborty, Meekha M Varghese, Darren P Wallace, Christopher J Ward, Alan S L Yu
American Journal of Physiology. Renal Physiology. 2026-09-21
Authored Content
- Magnesium Handling in the KidneyMay 2018
- Magnesium Handling in the KidneyMay 2018
- Total Kidney Volume in ADPKD Predicts CKD ProgressionJanuary 2018
Press Mentions
Why Black and Latino People Still Lag on COVID Vaccines — and How to Fix ItApril 26th, 2021- Do Less HarmJuly 10th, 2020
Notch4 Activation Aggravates NF-κB-Mediated Inflammation in HIV-1-Associated NephropathyDecember 17th, 2019
Grant Support
- Role of Claudin-2 in Calcium Homeostasis and Kidney Stone DiseaseUNIVERSITY OF KANSAS MEDICAL CENTER2019–2031
- The Kansas Institute for Precision MedicineUNIVERSITY OF KANSAS MEDICAL CENTER2019–2029
- The Kansas Institute for Precision MedicineUNIVERSITY OF KANSAS MEDICAL CENTER2019–2029
Other Languages
- Chinese (Cantonese)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: